Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
---|---|---|---|---|---|
SCRAJ-STT204 | Human | Raji/Membrane-Bound Human TL1A Stable Cell Line Development Service | |||
CHEK-ATP198 | Human | HEK293/Membrane-Bound human TL1A Stable Cell Line | |||
TLA-H5246 | Human | Human TL1A / TNFSF15 Protein, His Tag (Monomer) (MALS verified) |
|
||
CHEK-ATP142 | Human | HEK293/Human TL1A Stable Cell Line | |||
TLA-R5249 | Rat | Rat TL1A Protein, His Tag |
|
||
TLA-H5245 | Human | Human TL1A / TNFSF15 Protein, His Tag |
|
||
TLA-M5243 | Mouse | Mouse TL1A Protein, His Tag (HPLC-verified) |
|
||
TLA-H5244 | Human | Human TL1A / TNFSF15 Protein, His Tag (MALS verified) |
|
||
TLA-H52Q1 | Human | Biotinylated Human TL1A / TNFSF15 Protein, His,Avitag™ |
|
||
TLA-C5241 | Cynomolgus / Rhesus macaque | Cynomolgus/Rhesus macaque TL1A / TNFSF15 Protein, His Tag |
|
||
TLA-H5243 | Human | Human TL1A / TNFSF15 Protein, His Tag, active trimer (MALS verified) |
|
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Tulisokibart | MK-7240; PRA023; PRA-023 | Phase 3 Clinical | Prometheus Biosciences Inc, Merck Sharp & Dohme LLC | Inflammatory Bowel Diseases; Lung Diseases, Interstitial; Colitis, Ulcerative; Scleroderma, Diffuse; Crohn Disease | Details |
TEV-48574 | TEV-48574; TEV-574; TEV574 | Phase 2 Clinical | Teva Pharmaceutical Industries Ltd | Colitis, Ulcerative; Asthma; Crohn Disease | Details |
RVT-3101 | PF-06480605; PF 6480605; RVT-3101 | Phase 2 Clinical | Pfizer Inc | Inflammatory Bowel Diseases; Colitis, Ulcerative; Crohn Disease | Details |
Next-generation anti-TL1A antibody(Telavant) | Phase 1 Clinical | Telavant Inc | Fibrosis; Inflammation | Details | |
Tulisokibart | MK-7240; PRA023; PRA-023 | Phase 3 Clinical | Prometheus Biosciences Inc, Merck Sharp & Dohme LLC | Inflammatory Bowel Diseases; Lung Diseases, Interstitial; Colitis, Ulcerative; Scleroderma, Diffuse; Crohn Disease | Details |
TEV-48574 | TEV-48574; TEV-574; TEV574 | Phase 2 Clinical | Teva Pharmaceutical Industries Ltd | Colitis, Ulcerative; Asthma; Crohn Disease | Details |
RVT-3101 | PF-06480605; PF 6480605; RVT-3101 | Phase 2 Clinical | Pfizer Inc | Inflammatory Bowel Diseases; Colitis, Ulcerative; Crohn Disease | Details |
Next-generation anti-TL1A antibody(Telavant) | Phase 1 Clinical | Telavant Inc | Fibrosis; Inflammation | Details |
This web search service is supported by Google Inc.